With multiple novel therapies expected and the treatment paradigm shifting toward earlier intervention, the US EoE market ...

Basilea has acquired the global rights for Venatorx Pharmaceuticals’ ceftibuten-ledaborbactam etzadroxil, an antibiotic being ...

Apertura Gene Therapy has entered several licensing agreements to advance CNS treatments using its TfR1 CapX technology.

AbbVie is investing $195m to strengthen domestic API production, with the expansion of its manufacturing plant in North ...

Amphastar has signed an exclusive license agreement with Anji for the development, production, use and commercialisation of 3 ...

PureTech's latest spinoff Celea Therapeutics was created to progress the former's lead respiratory IPF programme, ...

Insmed’s drug Brinsupri (brensocatib) has landed a double regulatory landmark win, becoming both the first marketed ...

Despite posting record Q2 growth for its blockbuster weight loss and diabetes drug tirzepatide, Eli Lilly is facing legal ...

Ovarian cancer is one of the most challenging malignancies in oncology. Despite advances in diagnosis and treatment, it is ...

This will be the first time the option has been taken up since it was introduced at the beginning of 2025, under the Medical ...

Fosun Pharma Industrial has entered a licence agreement to grant ex-China rights for its respiratory drug, XH-S004, to Expedition.

Vinay Prasad resumes leadership at the FDA’s CBER two weeks after he resigned amid cell and gene therapy controversy.